AstraZeneca Stock Tumbles as Heart Drug Trial Fails
AstraZeneca stock drops following unexpected failure of a heart disease drug trial.
AstraZeneca stock drops following unexpected failure of a heart disease drug trial.
Taiwan officials issue a rare public warning on leveraged stock buying amid a historic market rally, highlighting risks from elevated margin debt…
Chinese memory chipmaker CXMT's $4.3 billion Shanghai IPO next week targets memory chip capacity growth, lifting semiconductor sector outlook.
Crypto markets could gain if the Federal Reserve intervenes to prevent a U.S. stock market crash, as policymakers are incentivized to backstop…
The Federal Reserve's June meeting minutes show a growing faction of officials favor additional rate hikes to combat inflation, sparking a rally…
Analysts see more upside for SpaceX stock as major brokerages issue buy ratings and begin research following the company's $75 billion June…
SpaceX's Nasdaq 100 addition and multiple Wall Street 'buy' ratings are poised to fuel a short-term stock rally as index-tracking funds buy…
Wall Street turns bullish on India’s stock markets as declining oil prices reduce import costs and strengthen the rupee, driving Nifty 50…
Hertz short interest hits an all-time high as shares plummet 60% in 2026, with bearish investors betting on continued weakness in the…
Dip buyers pushed tech stocks higher, with Nvidia rebounding from last week's chip pullback, signaling renewed confidence in AI demand.
SpaceX joins the Nasdaq 100 after a record-setting IPO, but previous entrants like Palantir and Strategy warn that inclusion frequently sparks volatility…
AI-driven stock rally stalls as investors rotate into old-guard value stocks, signaling a potential shift from growth to value amid tech valuation…